Cellulite Cream Manufactured By Phosphagenics Set For Global Debut

January 27, 2011

Phosphagenics, which is a biotechnology company out of Australia, has started focus groups in the United States for their new cellulite cream. Their newest cosmetic product uses their own patented TPM delivery system combined with novel lipolytic peptide, which is currently being licensed from Calzada.

Phosphagenics claims this new product is designed to minimize the appearance of cellulite, which is something that most people will find helpful. This new cellulite cream contains novel peptide, which was founded at Monash University. This ingredient has undergone testing over several years to determine just how well it can breakdown the fat that is stored inside fat cells. Combing novel peptide with Phosphagenics TPM delivery system increases the delivery method of the active ingredients when compared with other topical products.

The company plans to launch the product in Australia first, sometime between March and April. After the focus group studies have been completed in the United States, which takes about eight weeks, the product will be launched for consumers in the United States.

 

Source: http://pharmalive.com/News/index.cfm?articleid=754744&categoryid=10

Back